Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04518644
Title Nilotinib, for Patients With CML-CP or CML-AP
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

chronic myeloid leukemia

Therapies

Nilotinib

Age Groups: adult | senior
Covered Countries


No variant requirements are available.